EGFR mutation status in Tunisian non-small-cell lung cancer patients evaluated by mutation-specific immunohistochemistry

EGFR mutation status in Tunisian non-small-cell lung cancer patients evaluated by mutation-specific immunohistochemistry

Abstract Background Screening mutations in epidermal growth factor receptor (EGFR) to analyze non-small-cell lung cancer (NSCLC) profile is the criterion to choose the best therapeutic strategy. New Oncology guidelines recommend EGFR mutation analysis before prescribing tyrosine kinase inhibitors (T...

Full description

Bibliographic Details
Main Authors: Zohra Mraihi, Jihen Ben Amar, Hend Bouacha, Soumaya Rammeh, Lamia Hila
Format: Article
Language:English
Published: BMC 2018-08-01
Series:BMC Pulmonary Medicine
Subjects:
EGFR
Non-small-cell lung cancer
Mutation-specific immunohistochemistry
Targeted therapy
Online Access:http://link.springer.com/article/10.1186/s12890-018-0706-5

Internet

http://link.springer.com/article/10.1186/s12890-018-0706-5

Similar Items